References
- Raices M, D'Angelo MA. Nuclear pore complex composition: a new regulator of tissue-specific and developmental functions. Nat Rev Mol Cell Biol. 2012;13(11):687–699.
- Chatel G, Fahrenkrog B. Dynamics and diverse functions of nuclear pore complex proteins. Nucleus. 2012;3(2):162–171.
- Agudo D, Gómez-Esquer F, Martínez-Arribas F, et al.Nup88mRNA overexpression is associated with high aggressiveness of breast cancer. Int J Cancer. 2004;109(5):717–720.
- Zhao ZR, Zhang LJ, Wang YY, et al. Increased serum level of Nup88 protein is associated with the development of colorectal cancer. Medical Oncology. 2012;29(3):1789–1795.
- Takahashi N, van Kilsdonk JW, Ostendorf B, et al. Tumor marker nucleoporin 88kDa regulates nucleocytoplasmic transport of NF-κB. Biochem Biophys Res Commun. 2008;374(3):424–430.
- Karacosta LG, Kuroski LA, Hofmann WA, et al. Nucleoporin 62 and Ca2+/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells. Prostate. 2016;76(3):294–306.
- Hazawa M, Lin DC, Kobayashi A, et al. ROCK-dependent phosphorylation ofNUP62 regulates p63 nuclear transport and squamous cell carcinoma proliferation. EMBO Rep. 2018;19(1):73–88.
- Kinoshita Y, Kalir T, Rahaman J, et al. Alterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy. Am J Pathol. 2012;180(1):375–389.
- Takeda A, Yaseen NR. Nucleoporins and nucleocytoplasmic transport in hematologic malignancies. Semin Cancer Biol. 2014;27:3–10.
- Kikutake C, Yahara K. Identification of epigenetic biomarkers of lung adenocarcinoma through multi-omics data analysis. PLoS One. 2016;11(4):e0152918.
- Gu Q, Hou W, Liu H, et al. Nup210 and MicroRNA-22 modulate Fas to elicit HeLa cell cycle arrest. Yonsei Med J. 2020;61(5):371–381.
- Hong SH, Son KH, Ha SY, et al. Nucleoporin 210 serves a key scaffold for SMARCB1 in liver cancer. Cancer Res. 2021;81(2):356–370.
- Ley TJ, Miller C, Ding L, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368(22):2059–2074.
- GTEx Consortium. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45(6):580–585.
- GTEx Consortium. The genotype-tissue expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science. 2015;348(6235):648–660.
- Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the xena platform. Nat Biotechnol. 2020;38(6):675–678.
- Kraemer D, Wozniak RW, Blobel G, et al. The human CAN protein, a putative oncogene productassociated with myeloid leukemogenesis, is a nuclear pore complex protein thatfaces the cytoplasm.. Proc Natl Acad Sci USA. 1994;91(4):1519–1523.
- Franks TM, McCloskey A, Shokirev MN, et al. Nup98 recruits the Wdr82-Set1A/COMPASS complex to promoters to regulate H3K4 trimethylation in hematopoietic progenitor cells. Genes Dev. 2017;31(22):2222–2234.
- Petit A, Ragu C, Della-Valle V, et al. NUP98-HMGB3: a novel oncogenic fusion. Leukemia. 2010;24(3):654–658.
- Kaltenbach S, Soler G, Barin C, et al. NUP98-MLL fusion in human acute myeloblastic leukemia. Blood. 2010;116(13):2332–2335.
- Makise M, Nakamura H, Kuniyasu A. The role of vimentin in the tumor marker Nup88-dependent multinucleated phenotype. BMC Cancer. 2018;18(1):519.
- Naylor RM, Jeganathan KB, Cao X, et al. Nuclear pore protein NUP88 activates anaphase-promoting complex to promote aneuploidy. J Clin Invest. 2016;126(2):543–559.